Predict your next investment

INTERNET | Internet Software & Services / Data & Document Management
cueup.com

See what CB Insights has to offer

Founded Year

2009

Stage

Asset Sale | AssetsPurchased

Total Raised

$4.72M

About Cue

Cue, formerly Greplin, s a free service that turns emails, contacts and calendars into an intelligent snapshot of a user's day. Cue prepares an overview of events by linking together related phone numbers, addresses, tickets, invitations, receipts, files and more.

Cue Headquarter Location

San Francisco, California, 94101,

United States

Latest Cue News

Cue Announces Collaboration With Johnson & Johnson Innovation and Janssen Pharmaceuticals, Inc. to Accelerate Development of Quantitative HIV Viral Load Test for Resource Poor Settings

Feb 4, 2016

SAN DIEGO, CA--(Marketwired - Feb 4, 2016) - Cue, Inc. today announced a collaboration with Janssen Pharmaceuticals, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson, (Janssen) to address a significant global health need for HIV viral load testing using Cue's Lab-In-A-Box proprietary molecular diagnostics platform. The deal was facilitated by Johnson & Johnson Innovation. Today, access to HIV viral load testing in resource poor settings is limited due to cost, and the technical complexity of the instrumentation and infrastructure required. An affordable, portable, easy-to-use, and internet enabled HIV quantitative viral load test could significantly enhance access to clinically significant information. Patients with newly emerging viral load who remain on failing regimens run the risk of both disease progression and developing resistance to future treatment options. Hence, HIV viral load testing is key to optimal disease management in people living with HIV. The scale of the HIV epidemic in Africa, India, Southeast Asia, and other parts of the developing world make this a significant global health challenge to be solved through strategic coordination between diagnostics, therapy, and on-the-ground deployment. "We're excited to work with Janssen, a leader in the HIV field, to accelerate the development of the HIV quantitative viral load test on Cue's platform. Together we can make a big impact on this significant global health challenge by bringing simplicity, immediacy and affordability to the field of HIV viral load testing in an unprecedented way," says Cue CEO Ayub Khattak. About Cue Cue Inc. is developing a molecular diagnostics platform for portable, connected, easy-to-use detection and quantification of molecular targets with applications to consumer health and fitness, longitudinal monitoring of biomarkers for chronic disease management, and infectious disease detection in support of global health initiatives.

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Cue Patents

Cue has filed 31 patents.

The 3 most popular patent topics include:

  • Analytical chemistry
  • Laboratory equipment
  • Chromatography
patents chart

Application Date

Grant Date

Title

Related Topics

Status

10/27/2016

10/26/2021

Laboratory equipment, Analytical chemistry, Fluid dynamics, Seabird colonies, Biotechnology

Grant

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Application Date

10/27/2016

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Grant Date

10/26/2021

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Title

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Related Topics

Laboratory equipment, Analytical chemistry, Fluid dynamics, Seabird colonies, Biotechnology

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Grant

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.